Drug intelligence / Profile preview

Sinetrol Xpur

Development stage
Unknown
Lead developer
Fytexia
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Sinetrol Xpur is a standardized, proprietary blend of polyphenol-rich citrus fruit extracts (including grapefruit, orange, and red/blood orange) and guarana seed extract, developed as a dietary supplement primarily for weight management and metabolic health. The main active compounds are citrus flavanones—naringin and hesperidin (>40% as flavanones)—with caffeine as a secondary component (approximately 3.5%). Sinetrol Xpur has been clinically shown to promote lipolysis (fat breakdown), increase resting energy expenditure, and enhance adipose tissue "beiging," which shifts white adipose tissue toward a more metabolically active, energy-burning state. Mechanistically, it activates the breakdown of triglycerides and upregulates uncoupling protein (UCP) expression, contributing to improved body composition (fat mass reduction without loss of lean mass), lower inflammation (CRP, fibrinogen), improved oxidative stress markers, and positive modulation of gut microbiota relevant for metabolic benefits. It does not contain synephrine. Multiple randomized, double-blind, placebo-controlled clinical trials have shown statistically significant reductions in body weight, BMI, fat mass, and waist/hip circumference in overweight and obese adults. No significant adverse effects or changes in hepatic, renal, or lipid function were noted in trials.

Brand names
Sinetrol XpurSinetrol-XPur
Other names
Sinetrol XpurSinetrol-XPur
02

Targets

KDM1A (LSD1)ADRB2 (β2)UCP2 (Uncoupling protein 2)

Beyond the preview

Go deeper on Sinetrol Xpur.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinetrol Xpur.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call